← Browse by Condition
Medical Condition

rhegmatogenous retinal detachment

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 3, Phase 1, Phase 2, Phase 4

ClinicalMetric tracks all active clinical trials for rhegmatogenous retinal detachment sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
1
Top Sponsors
Massachusetts Eye and Ear Infirmary 2 trials
Queen's University, Belfast 1 trial
Clinical Hospital Center, Split 1 trial
NCT06997874 Phase 3
Recruiting

Treatment of Retinal Detachment in People Who Have Not Had Cataract Surgery With Vitrectomy vs Vitrectomy and Cataract Removal

Enrollment
276 pts
Location
United Kingdom
Sponsor
Queen's University, Belfast
View Trial →
NCT06033703 Phase 1, Phase 2
Recruiting

Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment

Enrollment
48 pts
Location
United States
Sponsor
Massachusetts Eye and Ear Infi...
View Trial →
NCT06694259
Recruiting

Comparison of Anatomical and Functional Outcomes of Laser Photocoagulation and Cryopexy in Patients with Rhegmatogenous Retinal Detachment Treated with Pneumatic Retinopexy

Enrollment
40 pts
Location
Croatia
Sponsor
Clinical Hospital Center, Spli...
View Trial →
NCT05331664 Phase 4
Recruiting

Dropless Pars Plana Vitrectomy Study

Enrollment
168 pts
Location
United States
Sponsor
Massachusetts Eye and Ear Infi...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology